Gilead Sciences (GILD) will raise its quarterly dividend by 2.8 percent to $0.73 per share in 2022. The biopharmaceutical company has now raised its dividend for the 7th consecutive year.
This post will be updated later.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases (hepatitis C and hepatitis B), cardiovascular, hematology/oncology and inflammation/respiratory. Gilead became a public company in 1992 and has been paying a dividend since 2015. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.